DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported
In Brief: Changes In Key Subcommittee chairmanships, Brooke’s Defeat Leave Direction In Doubt
Toxicity Testing Reorganization Announced; Rall To Head It Up
DCT Planning To Stop Use Monkeys In Preclinical Test
Grantees Seek $433.5 Million for construction
Leffall New ACS President, Gudberg, President-Elect
Trending Stories
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - Imaging’s ride to the bottom in clinical trials—and why it matters now
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- NIH says it’s moving away from animal-based models
- The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic - ODAC nixes GSK’s Blenrep myeloma regimens, citing ocular toxicity, dosing, applicability to U.S. population